Fol. Biol. 2020, 66, 169-178

https://doi.org/10.14712/fb2020066050169

Bosnian Study on Markers of Ischaemic Stroke in Adults 20–50 Years Old (SMISAO): Preliminary Report

Nevena Mahmutbegović1, A. Mehicevic1, Grażyna Adler2, I. Omerhodzic3, E. Mahmutbegovic4, A. Valjevac5, K. Borecki2, E. Mehmedika Suljic1

1Department of Neurology, Clinical Center of Sarajevo University, Sarajevo, Bosnia and Herzegovina
2Department of Studies in Antropogenetics and Biogerontology, Pomeranian Medical University, Szczecin, Poland
3Department of Neurosurgery, Clinical Center of Sarajevo University, Sarajevo, Bosnia and Herzegovina
4Institution of Health Protection of Women and Motherhood Canton Sarajevo, Sarajevo, Bosnia and Herzegovina
5Department of Human Physiology, Faculty of Medicine, University of Sarajevo, Sarajevo, Bosnia and Herzegovina

Received September 2020
Accepted December 2020

References

1. Adams, H. P., Jr, Bendixen, B. H., Kappelle, L. J., Biller, J., Love, B. B., Gordon, D. L., Marsh, E. E., 3rd (1993) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24, 35-41. <https://doi.org/10.1161/01.STR.24.1.35>
2. Aigner, A., Grittner, U., Rolfs, A., Norrving, B., Siegerink, B., Busch, M. A. (2017) Contribution of established stroke risk factors to the burden of stroke in young adults. Stroke 48, 1744-1751. <https://doi.org/10.1161/STROKEAHA.117.016599>
3. Akhter, M. S., Biswas, A., Abdullah, S. M., Behari, M., Saxena, R. (2017) The role of PAI-1 4G/5G promoter polymorphism and its levels in the development of ischemic stroke in young Indian population. Clin. Appl. Thromb. Hemost. 23, 1071-1076. <https://doi.org/10.1177/1076029617705728>
4. Alakbarzade, V., Taylor, A., Scully, M., Simister, R., Chandratheva, A. (2018) Utility of current thrombophilia screening in young patients with stroke and TIA. Stroke Vasc. Neurol. 3, 231-236. <https://doi.org/10.1136/svn-2018-000169>
5. Attia, J., Thakkinstian, A., Wang, Y., Lincz, L., Parsons, M., Sturm, J., McGettigan, P., Scott, R., Meldrum, C., Levi, C. (2007) The PAI-1 4G/5G gene polymorphism and ischemic stroke: an association study and meta-analysis. J. Stroke Cerebrovasc. Dis. 16, 173-179. <https://doi.org/10.1016/j.jstrokecerebrovasdis.2007.03.002>
6. Bang, C. O., Park, H. K., Ahn, M. Y., Shin, H. K., Hwang, K. Y., Hong, S. Y. (2001) 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene and insertion/deletion polymorphism of the tissue-type plasminogen activator gene in atherothrombotic stroke. Cerebrovasc. Dis. 11, 294-299. <https://doi.org/10.1159/000047656>
7. Bentley, P., Peck, G., Smeeth, L., Whittaker, J., Sharma, P. (2010) Causal relationship of susceptibility genes to ischemic stroke: comparison to ischemic heart disease and biochemical determinants. PloS One 5, e9136. <https://doi.org/10.1371/journal.pone.0009136>
8. Campo, G., Pavasini, R., Pollina, A., Tebaldi, M., Ferrari, R. (2013) Coagulation factors and recurrence of ischemic and bleeding adverse events in patients with acute coronary syndromes. Thromb. Res. 132, 151-157. <https://doi.org/10.1016/j.thromres.2013.06.007>
9. Cao, Y., Chen, W., Qian, Y., Zeng, Y., Liu, W. (2014) Plasminogen activator inhibitor-1 4G/5G polymorphism and ischemic stroke risk: a meta-analysis in Chinese population. Int. J. Neurosci. 124, 874-881. <https://doi.org/10.3109/00207454.2014.886577>
10. Carey, R. M., Whelton, P. K. (2018) The 2017 American College of Cardiology/American Heart Association Hypertension Guideline: a resource for practicing clinicians. Ann. Intern. Med. 168, 359-360. <https://doi.org/10.7326/M18-0025>
11. Cheng, Y. C., Cole, J. W., Kittner, S. J., Mitchell, B. D. (2014) Genetics of ischemic stroke in young adults. Circ. Cardiovasc. Genet. 7, 383-392. <https://doi.org/10.1161/CIRCGENETICS.113.000390>
12. Chiasakul, T., De Jesus, E., Tong, J., Chen, Y., Crowther, M., Garcia, D., Chai-Adisaksopha, C., Messé, S. R., Cuker, A. (2019) Inherited thrombophilia and the risk of arterial ischemic stroke: a systematic review and meta-analysis. J. Am. Heart Assoc. 8, e012877. <https://doi.org/10.1161/JAHA.119.012877>
13. Cox, N., Johnson, S. A., Vazquez, S., Fleming, R. P., Rondina, M. T., Kaplan, D., Chauv, S., Fontaine, G. V., Stevens, S. M., Woller, S., Witt, D. M. (2017) Patterns and appropriateness of thrombophilia testing in an academic medical center. J. Hosp. Med. 12, 705-709. <https://doi.org/10.12788/jhm.2804>
14. Dawson, S., Hamsten, A., Wiman, B., Henney, A., Humphries, S. (1991) Genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasma plasminogen activator inhibitor-1 activity. Arterioscler. Thromb. 11, 183-190. <https://doi.org/10.1161/01.ATV.11.1.183>
15. Domingues-Montanari, S., Fernandez-Cadenas, I., del Rio- Espinola, A., Mendioroz, M., Ribo, M., Obach, V., Marti-Fabregas, J., Freijo, M., Serena, J., Corbeto, N., Chacon, P., Alvarez-Sabin, J., Montaner, J. (2010) The I/D polymorphism of the ACE1 gene is not associated with ischaemic stroke in Spanish individuals. Eur. J. Neurol. 17, 1390-1392. <https://doi.org/10.1111/j.1468-1331.2010.03022.x>
16. Dušanović Pjević, M., Beslac Bumbaširevic, L., Vojvodic, L., Grk, M., Maksimović, N., Damnjanović, T., Novaković, I., Kačar, K., Pesic, M., Perovic, D., Savic, M., Maksic, V., Trickovic, J., Jekic, B. (2019) Analysis of the association between polymorphisms within PAI-1 and ACE genes and ischemic stroke outcome after rt-PA therapy. J. Pharm. Pharm. Sci. 22, 142-149. <https://doi.org/10.18433/jpps30339>
17. Ekker, M. S., Boot, E. M., Singhal, A. B., Tan, K. S., Debette, S., Tuladhar, A. M., de Leeuw, F. E. (2018). Epidemiology, aetiology, and management of ischaemic stroke in young adults. Lancet Neurol. 17, 790-801. <https://doi.org/10.1016/S1474-4422(18)30233-3>
18. Feigin, V. L., Roth, G. A., Naghavi, M., Parmar, P., Krishnamurthi, R., Chugh, S., Mensah, G. A., Norrving, B., Shiue, I., Ng, M., Estep, K., Cercy, K., Murray, C., Forouzanfar, M. H., Global Burden of Diseases, Injuries and Risk Factors Study 2013 and Stroke Experts Writing Group (2016) Global burden of stroke and risk factors in 188 countries, during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet Neurol. 15, 913-924. <https://doi.org/10.1016/S1474-4422(16)30073-4>
19. Francis C. W. (2002) Plasminogen activator inhibitor-1 levels and polymorphisms. Arch. Pathol. Lab. Med. 126, 1401-1404. <https://doi.org/10.5858/2002-126-1401-PAILAP>
20. George, M. G., Tong, X., Bowman, B. A. (2017) Prevalence of cardiovascular risk factors and strokes in younger adults. JAMA Neurol. 74, 695-703. <https://doi.org/10.1001/jamaneurol.2017.0020>
21. Glenn, K. L., Du, Z. Q., Eisenmann, J. C., Rothschild, M. F. (2009) An alternative method for genotyping of the ACE I/D polymorphism. Mol. Biol. Rep. 36, 1305-1310. <https://doi.org/10.1007/s11033-008-9313-5>
22. Grundy, S. M., Stone, N. J., Bailey, A. L., Beam, C., Birtcher, K. K., Blumenthal, R. S., Braun, L. T., de Ferranti, S., Faiella-Tommasino, J., Forman, D. E., Goldberg, R., Heidenreich, P. A., Hlatky, M. A., Jones, D. W., Lloyd-Jones, D., Lopez-Pajares, N., Ndumele, C. E., Orringer, C. E., Peralta, C. A., Saseen, J. J., Smith, S.C. Jr., Sperling, L., Virani, S.S.,Yeboah, J. (2019) 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: executive summary: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. J. Am. Coll. Cardiol. 73, 3168-3209. <https://doi.org/10.1016/j.jacc.2018.11.002>
23. Haskell, W. L., Lee, I. M., Pate, R. R., Powell, K. E., Blair, S. N., Franklin, B. A., Macera, C. A., Heath, G. W., Thompson, P. D., Bauman, A., American College of Sports Medicine, American Heart Association (2007) Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Circulation 116, 1081-1093. <https://doi.org/10.1161/circ.116.suppl_16.II_940-d>
24. Hu, X., Zan, X., Xie, Z., Li, Y., Lin, S., Li, H., You, C. (2017) Association between plasminogen activator inhibitor-1 genetic polymorphisms and stroke susceptibility. Mol. Neurobiol. 54, 328-341. <https://doi.org/10.1007/s12035-015-9549-8>
25. Isordia-Salas, I., Santiago-Germán, D., Cerda-Mancillas, M. C., Hernández-Juárez, J., Bernabe-García, M., Leaños- Miranda, A., Alvarado-Moreno, J. A., Majluf-Cruz, A. (2019) Gene polymorphisms of angiotensin-converting enzyme and angiotensinogen and risk of idiopathic ischemic stroke. Gene 688, 163-170. <https://doi.org/10.1016/j.gene.2018.11.080>
26. Ji, R., Schwamm, L. H., Pervez, M. A., Singhal, A. B. (2013) Ischemic stroke and transient ischemic attack in young adults: risk factors, diagnostic yield, neuroimaging, and thrombolysis. JAMA Neurol. 70, 51-57. <https://doi.org/10.1001/jamaneurol.2013.575>
27. Jovanović, D. R., Beslać-Bumbasirević, L., Raicević, R., Zidverć-Trajković, J., Ercegovac, M. D. (2008) Etiology of ischemic stroke among young adults of Serbia. Vojnosanit. Pregl. 66, 803-809. <https://doi.org/10.2298/VSP0811803J>
28. Karagiannis, A., Balaska, K., Tziomalos, K., Tokalaki- Nikolaidou, L., Papayeoryiou, A., Zamboulis, C. (2004) Lack of an association between angiotensin-converting enzyme gene insertion/deletion polymorphism and ischaemic stroke. Eur. Neurol. 51, 148-152. <https://doi.org/10.1159/000077203>
29. Konialis, C., Spengos, K., Iliopoulos, P., Karapanou, S., Gialafos, E., Hagnefelt, B., Vemmos, K., Zakopoulos, N., Pangalos, C. (2016) The APOE E4 allele confers increased risk of ischemic stroke among Greek carriers. Adv. Clin. Exp. Med. 25, 471-478. <https://doi.org/10.17219/acem/38841>
30. Lindpaintner, K., Pfeffer, M. A., Kreutz, R., Stampfer, M. J., Grodstein, F., LaMotte, F., Buring, J., Hennekens, C. H. (1995) A prospective evaluation of an angiotensin-converting- enzyme gene polymorphism and the risk of ischemic heart disease. N. Engl. J. 332, 706-711. <https://doi.org/10.1056/NEJM199503163321103>
31. Omran, S. S., Lerario, M. P., Gialdini, G., Merkler, A. E., Moya, A., Chen, M. L., Kamel, H., DeSancho, M., Navi, B. B. (2019) Clinical impact of thrombophilia screening in young adults with ischemic stroke. J. Stroke Cerebrovasc. Dis. 28, 882-889. <https://doi.org/10.1016/j.jstrokecerebrovasdis.2018.12.006>
32. Opstad, T. B., Pettersen, A. A., Weiss, T., Arnesen, H., Seljeflot, I. (2010) Gender differences of polymorphisms in the TF and TFPI genes, as related to phenotypes in patients with coronary heart disease and type-2 diabetes. Thromb. J. 8, 7. <https://doi.org/10.1186/1477-9560-8-7>
33. Pahus, S. H., Hansen, A. T., Hvas, A. M. (2016) Thrombophilia testing in young patients with ischemic stroke. Thromb. Res. 137, 108-112. <https://doi.org/10.1016/j.thromres.2015.11.006>
34. Poort, S. R., Rosendaal, F. R., Reitsma, P. H., Bertina, R. M. (1996) A common genetic variation in the 3’-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 88, 3698-3703. <https://doi.org/10.1182/blood.V88.10.3698.bloodjournal88103698>
35. Powers, W. J., Rabinstein, A. A., Ackerson, T., Adeoye, O. M., Bambakidis, N. C., Becker, K., Biller, J., Brown, M., Demaerschalk, B. M., Hoh, B., Jauch, E. C., Kidwell, C. S., Leslie-Mazwi, T. M., Ovbiagele, B., Scott, P. A., Sheth, K. N., Southerland, A. M., Summers, D. V., Tirschwell, D. L., American Heart Association Stroke Council (2018) 2018 Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 49, e46-e110. <https://doi.org/10.1161/STR.0000000000000158>
36. Putaala, J., Metso, A. J., Metso, T. M., Konkola, N., Kraemer, Y., Haapaniemi, E., Kaste, M., Tatlisumak, T. (2009) Analysis of 1008 consecutive patients aged 15 to 49 with firstever ischemic stroke: the Helsinki young stroke registry. Stroke 40, 1195-1203. <https://doi.org/10.1161/STROKEAHA.108.529883>
37. Putaala, J., Yesilot, N., Waje-Andreassen, U., Pitkäniemi, J., Vassilopoulou, S., Nardi, K., Odier, C., Hofgart, G., Engelter, S., Burow, A., Mihalka, L., Kloss, M., Ferrari, J., Lemmens, R., Coban, O., Haapaniemi, E., Maaijwee, N., Rutten-Jacobs, L., Bersano, A., Cereda, C., Baron, P., Borellini, L., Valcarenghi, C., Thomassen, L., Grau, A. J., Palm, F., Urbanek, C., Tuncay, R., Durukan-Tolvanen, A., van Dijk, E. J., de Leeuw, F. E., Thijs, V., Greisenegger, S., Vemmos, K., Lichy, C., Bereczki, D., Csiba, L., Michel, P., Leys, D., Spengos, K., Naess, H., Bahar, S. Z.,Tatlisumak, T. (2012) Demographic and geographic vascular risk factor differences in European young adults with ischemic stroke: the 15 cities young stroke study. Stroke 43, 2624-2630. <https://doi.org/10.1161/STROKEAHA.112.662866>
38. Ranellou, K., Paraskeva, A., Kyriazopoulos, P., Batistatou, A., Evangelou, A., El-Aly, M., Zis, P., Tavernarakis, A., Charalabopoulos, K. (2015) Polymorphisms in prothrombotic genes in young stroke patients in Greece: a case-controlled study. Blood Coagul. Fibrinolysis 26, 430-435. <https://doi.org/10.1097/MBC.0000000000000274>
39. Sartori, M. T., Danesin, C., Saggiorato, G., Tormene, D., Simioni, P., Spiezia, L., Patrassi, G. M., Girolami, A. (2003) The PAI-1 gene 4G/5G polymorphism and deep vein thrombosis in patients with inherited thrombophilia. Clin. Appl. Thromb. Hemost. 9, 299-307. <https://doi.org/10.1177/107602960300900405>
40. Schellekens, M., van Alebeek, M. E., Arntz, R. M., Synhaeve, N. E., Maaijwee, N., Schoonderwaldt, H. C., van der Vlugt, M. J., van Dijk, E. J., Rutten-Jacobs, L., de Leeuw, F. E. (2018) Prothrombotic factors do not increase the risk of recurrent ischemic events after cryptogenic stroke at young age: the FUTURE study. J. Thrombolysis 45, 504-511. <https://doi.org/10.1007/s11239-018-1631-4>
41. Smajlović, D., Salihović, D., Ibrahimagić, O. C., Sinanović, O. (2013) Characteristics of stroke in young adults in Tuzla Canton, Bosnia and Herzegovina. Coll. Antropol. 37, 515-519.
42. Stankovic, S., Stankovic, A., Asanin, M., Jovanovic-Markovic, Z., Alavantic, D., Majkic-Singh, N. (2010) The interaction of apolipoprotein E and angiotensin I-converting enzyme DNA polymorphisms with hypertension on early ischemic stroke risk. EJIFCC 21, 13-18.
43. Supanc, V., Sonicki, Z., Vukasovic, I., Solter, V. V., Zavoreo, I., Kes, V. B. (2014) The role of classic risk factors and prothrombotic factor gene mutations in ischemic stroke risk development in young and middle-aged individuals. J. Stroke Cerebrovasc. Dis. 23, e171-e176. <https://doi.org/10.1016/j.jstrokecerebrovasdis.2013.09.025>
44. Szolnoki, Z., Somogyvári, F., Kondacs, A., Szabó, M., Fodor, L., Bene, J., Melegh, B. (2003) Evaluation of the modifying effects of unfavourable genotypes on classical clinical risk factors for ischaemic stroke. J. Neurol. Neurosurg. Psychiatry 74, 1615-1620. <https://doi.org/10.1136/jnnp.74.12.1615>
45. Tasdemir, S., Erdem, H. B., Sahin, I., Ozel, L., Ozdemir, G., Eroz, R., Tatar, A. (2016) Correlation with platelet parameters and genetic markers of thrombophilia panel (factor II g.20210G>A, factor V Leiden, MTHFR (C677T, A1298C), PAI-1, β-fibrinogen, factor XIIIA (V34L), glycoprotein IIIa (L33P)) in ischemic strokes. Neuromolecular Med. 18, 170-176. <https://doi.org/10.1007/s12017-016-8386-x>
46. Turfan, M., Poyraz, F., Kaymak, A. Ö., Ergun, M. A., Tavil, Y., Gursel, T., Abaci, A. (2014) Plasma levels and distribution of gene polymorphisms of factor VII in Turkish population. Clin. Appl. Thromb. Hemost. 20, 164-168. <https://doi.org/10.1177/1076029612459676>
47. von Sarnowski, B., Putaala, J., Grittner, U., Gaertner, B., Schminke, U., Curtze, S., Huber, R., Tanislav, C., Lichy, C., Demarin, V., Basic-Kes, V., Ringelstein, E. B., Neumann-Haefelin, T., Enzinger, C., Fazekas, F., Rothwell, P. M., Dichgans, M., Jungehulsing, G. J., Heuschmann, P. U., Kaps, M., Norrving, B., Rolfs, A., Kessler, C., Tatlisumak, T., Sifap1 Investigators (2013) Lifestyle risk factors for ischemic stroke and transient ischemic attack in young adults in the stroke in young Fabry patients study. Stroke 44, 119-125. <https://doi.org/10.1161/STROKEAHA.112.665190>
48. Wei, L. K., Au, A., Menon, S., Griffiths, L. R., Kooi, C. W., Irene, L., Zhao, J., Lee, C., Alekseevna, A. M., Hassan, M., Aziz, Z. A. (2017) Polymorphisms of MTHFR, eNOS, ACE, AGT, ApoE, PON1, PDE4D, and ischemic stroke: meta-analysis. J. Stroke Cerebrovasc. Dis. 26, 2482-2493. <https://doi.org/10.1016/j.jstrokecerebrovasdis.2017.05.048>
49. Wiklund, P. G., Nilsson, L., Ardnor, S. N., Eriksson, P., Johansson, L., Stegmayr, B., Hamsten, A., Holmberg, D., Asplund, K. (2005) Plasminogen activator inhibitor-1 4G/5G polymorphism and risk of stroke: replicated findings in two nested case-control studies based on independent cohorts. Stroke 36, 1661-1665. <https://doi.org/10.1161/01.STR.0000174485.10277.24>
front cover

ISSN 0015-5500 (Print) ISSN 2533-7602 (Online)

Open access journal

Archive